Search company, investor...

Calibrant Biosystems


Dead | Dead

Total Raised


About Calibrant Biosystems

Calibrant Biosystems specializes in the discovery and validation of protein biomarkers. Calibrant's proprietary biomarker discovery platform enables quantitative protein profiling of human tissue samples. With sample requirements uniquely matched to microdissection methods including laser capture microdissection (LCM), and coupled with an integrated bioinformatics suite enabling effective data mining from combined genomic and proteomic data, Calibrant's approach to biomarker discovery provides unique benefits for drug discovery, drug development, and clinical diagnostics.

Headquarters Location

910 Clopper Road Ste 220n Suite 22N

Gaithersburg, Maryland, 20878,

United States


Missing: Calibrant Biosystems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Calibrant Biosystems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Calibrant Biosystems Patents

Calibrant Biosystems has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Biotechnology, Molecular biology, Microfluidics, Mass spectrometry, Electrophoresis


Application Date


Grant Date



Related Topics

Biotechnology, Molecular biology, Microfluidics, Mass spectrometry, Electrophoresis



Calibrant Biosystems Frequently Asked Questions (FAQ)

  • Where is Calibrant Biosystems's headquarters?

    Calibrant Biosystems's headquarters is located at 910 Clopper Road Ste 220n, Gaithersburg.

  • What is Calibrant Biosystems's latest funding round?

    Calibrant Biosystems's latest funding round is Dead.

  • How much did Calibrant Biosystems raise?

    Calibrant Biosystems raised a total of $14.88M.

  • Who are the investors of Calibrant Biosystems?

    Investors of Calibrant Biosystems include U.S. Department of Health and Human Services, U.S. Army, Defense Advanced Research Projects Agency and National Science Foundation.

  • Who are Calibrant Biosystems's competitors?

    Competitors of Calibrant Biosystems include Biolog, Oligomerix, Brandenburg, Sirnaomics, Dicerna Pharmaceuticals, Elusys Therapeutics, Intralytix, Oceanit, Pfenex, MOgene LC and 42 more.

Compare Calibrant Biosystems to Competitors

Biolog Logo

Biolog specializes in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi, as well as the characterization of human cells and mitochondria. Biolog's products are available worldwide, either directly from the company or through its extensive network of international distributors. The company was founded in 1984 and is based in Hayward, California.


CellXplore is a new, biotechnology company engaged in the development of biomarker-based in vitro diagnostic assays for cancer, initially focusing on breast cancer. Although mammography is an effective screening test for early detection, there is a need for a simple, reliable and sensitive biomarker-based in vitro assay that can be used to stage and characterize breast cancer.nThe company was formed to commercialize groundbreaking discoveries demonstrating up-regulation of the ubiquitin-proteasome pathway in cancerous breast tissue, providing the capability for the noninvasive detection of breast cancer and the ability to monitor the efficacy of chemotherapeutic interventions.nCellXplore's platform technology is not restricted to breast cancer in vitro diagnostics alone, nor is it restricted to cancer diagnostics alone. Beyond cancer, CellXplore is already investigating whether similar blood sample biomarkers can be identified for the early diagnosis of several major debilitating diseases such as muscle wasting, Alzheimer's disease, Parkinson's disease and inflammatory diseases.


Inscentinel Ltd is a biotechnology company specializing in harnessing the olfactory ability of insects for trace vapor detection. The company's primary focus is the development of handheld portable detectors, through the use of live honeybees. This Inscentinel Technology offers sensitive vapour detection coupled with distinct operational advantages.

CELLective Dx Corporation

CELLective Dx is an early-stage company developing a new generation of diagnostic tools for cancer based on analysis of CTCs directly from a patient's blood. Our novel proprietary technologies combine microfluidics, flow dynamics, cell biology, molecular biology, biochemistry, and surface chemistry to capture and analyze rare CTCs in blood more rapidly and effectively than other current technologies. CELLective Dx is developing simple, rapid, blood-based cancer tests that will provide physicians and patients with accurate and individualized clinical information on disease status, treatment selection, and treatment response that will dramatically improve the clinical management of cancer.


ARCXIS develops, produces, and distributes portable biological diagnostic tools with the ability to analyze, detect, and characterize infectious disease agents. It develops diagnostic tools for use in national defense, clinical diagnostics, as well as food and beverage applications. The company was founded in 2004 and is based in Houston, Texas.

Proteome Systems

Tyrian Diagnostics is a biotechnology company that specialises in the discovery of biomarkers of disease and in diagnostic test development. The company are building a strong intellectual property portfolio to develop a pipeline of diagnostic products and establishing commercial partnerships to maximise market share and revenue generation from these products. One key avenue for commercialisation is the application of biomarkers to the company's point of need test platform, DiagnostIQTM.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.